Questions regarding the cardiovascular safety of drugs prescribed for T2DM arose as individuals treated with sulfonylureas and insulin showed an increased incidence of major adverse cardiovascular events (MACEs: death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) [18, 19]
Semaglutide is a GLP-1 receptor agonist that mimics one natural hormone to reduce appetite
PlexusDx specializes in personalized semaglutide therapy and helps patients navigate these safety concerns with medical guidance and genetic insights
Intravital imaging To test if ABT treatment influences OTA transport kinetics, intravital imaging of OTA transport in the livers of mice pre-treated with PBS or ABT was performed using a two-photon microscope (LSM MP7, Zeiss, Germany), as previously described (Hassan 2016
This strategy can amplify not only weight loss but blood sugar control
Instead, it identifies predispositions in the biological pathways that GLP-1 agonists and DPP-4 inhibitors target